Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Illinois Tech Journal.
Press releases published on June 2, 2025
Scan5 Offers Photo Digitizing Services to Local Nonprofits
EIN Presswire
·
June 2, 2025
As part of its community outreach program, Scan5 will provide photo, film, and tape digitization at no cost to help local organizations preserve their history. CHICAGO, IL, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Scan5, a leading provider of …
CDG Integrates Elements OSS/BSS Platform with Nokia’s Altiplano and Corteca Cloud Platforms
EIN Presswire
·
June 2, 2025
CDG is pleased to announce its integration with Nokia’s Altiplano and Corteca Cloud platforms. CHAMPAIGN, IL, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Communications Data Group, Inc. (CDG), a leading provider of innovative OSS/BSS solutions for …
Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in Solid Tumors
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical …
Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory Patients in Oral Report
GlobeNewswire
·
June 2, 2025
ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from …
Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of NBI-1117568
GlobeNewswire
·
June 2, 2025
Tokyo, Japan and Cambridge, UK, 3 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner, Neurocrine Biosciences (“Neurocrine”) has dosed the first patient in its Phase 3 registrational program of NBI- …
Semilux Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 20-F
GlobeNewswire
·
June 2, 2025
Taipei, Taiwan, June 02, 2025 (GLOBE NEWSWIRE) -- Semilux International Ltd. (NASDAQ:SELX) (“SELX” or the “Company”) announced that it received a delinquency notification letter on May 27, 2025 (the “Deficiency Letter”) from the Listing Qualifications …
Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders
GlobeNewswire
·
June 2, 2025
VICTORIA, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …
FansHash Empowers Global Investors with Daily Passive Income via Cloud Mining
GlobeNewswire
·
June 2, 2025
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- As Bitcoin approaches its all-time high, Fanshash’s user-friendly, maintenance-free cloud mining platform has attracted a surge of miners, gaining significant momentum. Amid the latest crypto market rally, …
Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting
GlobeNewswire
·
June 2, 2025
– CR/CRh rate of 23% in pivotal Ph 2 cohort of R/R NPM1-m AML patients – – Consistent efficacy with comparable CR/CRh rates and clinically meaningful MRD-negative responses across pre-specified subgroups, regardless of prior HSCT, prior venetoclax, or FLT3 …
MDB Capital Holdings Announces Transitions In Its Board of Directors
GlobeNewswire
·
June 2, 2025
Addison, TX, June 02, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, today announced key leadership transitions within its Board …
Quest PharmaTech Provides Corporate Update
GlobeNewswire
·
June 2, 2025
EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary …
SunnyMining Gains Institutional Interest as Cloud Mining Sees Accelerated Adoption
GlobeNewswire
·
June 2, 2025
Boston, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- SunnyMining's latest report shows that as the popularity of cryptocurrencies continues to rise, an increasing number of users from platforms like Coinbase and Kraken are turning to cloud mining. …
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …
Harvard Bioscience Appoints John Duke to Board of Directors
GlobeNewswire
·
June 2, 2025
HOLLISTON, Mass., June 02, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating …
Cloud Mining in 2025: How VNBTC Is Reshaping Free Crypto Income Opportunities Globally
GlobeNewswire
·
June 2, 2025
London, UK, June 02, 2025 (GLOBE NEWSWIRE) -- As cloud mining becomes one of the fastest-growing passive income methods in the digital asset space, VNBTC, a free cloud mining platform, is rapidly gaining global recognition for making free cloud mining both …
Altai Announces Repositioning of Investment Portfolio to Maximize Liquidity
GlobeNewswire
·
June 2, 2025
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that the Company has completed the repositioning of its Canadian investment portfolio (the “Investment Portfolio”) through the sale of …
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
June 2, 2025
BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company’s 2025 …
ibex to Present at Baird's 2025 Global Consumer, Technology & Services Conference
GlobeNewswire
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- IBEX Limited (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and AI-powered customer engagement technology solutions, today announced that CEO Bob Dechant and CFO Taylor Greenwald …
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes
GlobeNewswire
·
June 2, 2025
MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they …
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
June 2, 2025
Meeting adjourned to June 13, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 12, 2025 Leading Independent Proxy Advisory Firms, ISS and Glass …